Who is sponsoring NCT05167968?

NCT05167968 is sponsored by Assistance Publique - Hôpitaux de Paris.

What drugs are being tested in NCT05167968?

Interventions in NCT05167968: No intervention (Observational cohort).

What condition does NCT05167968 study?

NCT05167968 studies Precapillary Pulmonary Hypertension.

Is NCT05167968 still recruiting?

NCT05167968 is currently completed. Last updated 11 February 2026.

Last reviewed 2026-02-11 · How we verify

NCT05167968: PHARE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Adherence of Diuretics in Pulmonary Hypertension

Completed Last updated 11 February 2026

What this trial tests

trial testing No intervention (Observational cohort) in Precapillary Pulmonary Hypertension in 227 participants. Completed in 24 January 2024.

Timeline

13 January 2022

Primary endpoint
24 January 2024

24 January 2024

Quick facts

Lead sponsor	Assistance Publique - Hôpitaux de Paris
Status	Completed
Study type	OBSERVATIONAL
Enrollment	227
Start date	13 January 2022
Primary completion	24 January 2024
Estimated completion	24 January 2024
Sites	1 location across France

Drugs / interventions tested

No intervention (Observational cohort)

Conditions studied

Precapillary Pulmonary Hypertension — all drugs for Precapillary Pulmonary Hypertension →

Sponsor

Assistance Publique - Hôpitaux de Paris — full company profile →

Who can join

18 and older, any sex, with Precapillary Pulmonary Hypertension. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this prospective study, the investigators will implement a systematic assessment of adherence to diuretics in a cohort of patients with precapillary pulmonary hypertension. This study is designed to: * determine the overall adherence rates for diuretic regimen * determine the determinants of non-adherence to diuretics * assess the risk of PH worsening occurrence in the non-adhesion group

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Diuretic adherence in patients with pre-capillary pulmonary hypertension: insights from the PHARE study.
Le Bozec A, Cohen SD, Montani D, Boucly A, et al · · 2025 · PMID 41257177 · DOI 10.1183/23120541.00110-2025

Verify or expand the search:

Other Assistance Publique - Hôpitaux de Paris trials

Trials by the same sponsor.

NCT07443436 — Immunomodulatory Treatment of Interstitial Lung Disease Associated With Surfactant Related Gene Variants · Phase 2 · not yet recruiting
NCT07499492 — Red Blood Cell Transfusion to Optimize Extubation · NA · not yet recruiting
NCT07379918 — Real-life Evaluation of Endopredict® in Early HR+/HER2- Breast Cancer · recruiting
NCT07473869 — Smartphone Application for Automated Measurement of Capillary Refill Time (CRT) · not yet recruiting
NCT07505394 — Efficacy of a Prediction Model-based Algorithm to PREVENT Drug-induced Impulse Control Disorders in Parkinson's Disease · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05167968 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assistance Publique - Hôpitaux de Paris
Last refreshed: 11 February 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05167968.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing